|Bid||8.74 x 1100|
|Ask||9.25 x 900|
|Day's Range||8.29 - 9.16|
|52 Week Range||6.51 - 33.41|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||25.33|
Subscribe to Yahoo Finance Plus to view Fair Value for AMLX
CAMBRIDGE, Mass., May 16, 2022--Amylyx announced the publication of long-term prespecified analyses in the Journal of Neurology, Neurosurgery and Psychiatry (JNNP).
CAMBRIDGE, Mass., May 12, 2022--Amylyx Pharmaceuticals Reports First Quarter 2022 Financial Results
If you want to know who really controls Amylyx Pharmaceuticals, Inc. ( NASDAQ:AMLX ), then you'll have to look at the...